10x Genomics, Inc. (TXG)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$1.03B
Stockholders' Equity
$825.5M
Cash & Equivalents
$502.5M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, 10x Genomics, Inc. reported revenue of $151.0M, net income of -$17.9M, and total assets of $1.03B. Every figure below is taken directly from 10x Genomics, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2017–FY2025 · as reported

$642.8M$50.0M-$542.7M
FY2017FY2019FY2021FY2023FY2025
Revenue$642.8MNet income-$43.5M
FY2017 revenue
$71.1M
FY2025 revenue
$642.8M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$642.8M-$43.5M
FY2024$610.8M-$182.6M
FY2023$618.7M-$255.1M
FY2022$516.4M-$166.0M
FY2021$490.5M-$58.2M
FY2020$298.8M-$542.7M
FY2019$245.9M-$31.3M
FY2018$146.3M-$112.5M
FY2017$71.1M-$18.8M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QAug 7, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
8-KJun 8, 2026on EDGAR ↗
10-QMay 8, 2026on EDGAR ↗
8-KMay 7, 2026on EDGAR ↗
DEF 14AApr 24, 2026on EDGAR ↗
10-KFeb 13, 2026on EDGAR ↗
8-KFeb 12, 2026on EDGAR ↗
8-KJan 12, 2026on EDGAR ↗
8-KNov 14, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$1.03Bsource ↗
Stockholders’ Equity$825.5Msource ↗
Cash & Equivalents$502.5Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$151.0Msource ↗
Net Income-$17.9Msource ↗
Operating Income-$19.6Msource ↗
Gross Profit$112.5Msource ↗
Cost of Revenue$38.5Msource ↗
R&D Expense$56.8Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.14source ↗
EPS (basic)$-0.14source ↗
Shares Outstanding—source ↗
Cash from Operations$17.0Msource ↗
Cash from Financing$3.0Msource ↗
Cash from Investing-$7.7Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
38
Net shares
-278.2K

Restatement history

Point-in-time

No material restatements detected across 246 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches TXG’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TXG

MCP tool: get_sec_fundamentals ticker=TXG

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TXG/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=TXG as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TXG/history

MCP tool: get_fundamentals_history ticker=TXG

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/TXG

MCP tool: get_financial_health ticker=TXG

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.